EIZO Corporation
Notice Regarding Revision of Medium-Term Management Plan
A progress review of the 8th Medium-Term Management Plan announced in May 2024 was conducted, and numerical targets for the fiscal year ending March 2027 are under reconsideration due to changes in the business environment. The growth strategy continues, and shareholder returns are planned to increase dividends for the 13th consecutive period.
Key Figures
- Policy Holding Stock Ratio: 20.1% (End of December 2025)
- Shareholder Returns: Planned 13 consecutive dividend increases (FY March 2026)
- Fixed Costs: Planned control to the level of 25F
AI要約
Review of Performance Targets and Business Environment Recognition
A progress review of the 8th Medium-Term Management Plan announced in May 2024 was conducted. Considering significant changes in the business environment such as prolonged stagnation in the European market, numerical targets for the fiscal year ending March 2027 are under careful examination for revision. The fundamental policy is to solve social issues through products and services that maximize visual value and expand business domains, with no change in the direction of the growth strategy.
Promotion of Growth and Financial Strategies
Efforts are underway to develop new markets in India and the Middle East and expand market share in the US-China healthcare markets to reduce reliance on the European market. The EVS business is being promoted to enhance competitiveness through cross-selling reinforcement and new product launches. Financial strategy continues with recovery of earning power and net asset control despite not achieving ROE of 8%, and reduction of policy holding stocks is progressing. Shareholder returns plan flexible share buybacks and 13 consecutive dividend increases.
